A comprehensive review of current tactics in the therapeutic management of Parkinson's disease, this volume offers summaries of salient research findings as well as contemporary attitudes and practical advice from field specialists. The well-timed Third Edition is expanded and topically reorganized to register trends and progress in anti-parkinsonian medications, ablative surgical options, deep brain stimulation, nonmotor symptom treatments, nonmedical strategies, and investigational therapies.
A comprehensive review of current tactics in the therapeutic management of Parkinson's disease, this volume offers summaries of salient research findings as well as contemporary attitudes and practical advice from field specialists. The well-timed Third Edition is expanded and topically reorganized to register trends and progress in anti-parkinsonian medications, ablative surgical options, deep brain stimulation, nonmotor symptom treatments, nonmedical strategies, and investigational therapies.
Rajesh Pahwa, University of Kansas Medical Center, Kansas City. Kelly E. Lyons, Ph.D University of Kansas Medical Center. William Koller
Inhaltsangabe
Background: early iconography of Parkinson's disease Christopher G. Goetz. Clinical aspects: epidemiology of Parkinsonism Ali H. Rajput Alex Rajput and Michele Rajput; differential diagnosis of Parkinsonism Kapil D. Sethi; pathophysiology and clinical assessment of Parkinsonian symptoms and signs Joseph Jankovic; nonmotor symptoms of Parkinson's disease Richard B. Dewey Jr; neuropsychological aspects of Parkinson's disease and Parkinsonian syndromes Alexander I. Troster and Steven Paul Woods; treatment of mental changes Jorge Juncos; neuroimaging in Parkinson's disease Kenneth Marek Danna Jennings and John Seibyl. Pathology and neurochemistry: neuropathology of Parkinsonism Dennis W. Dickson; neurochemistry Jayaraman Rao; neurophysiology/circuitry Erwin Montgomery; animal models of Parkinson's disease and related disorders Giselle M. Petzinger and Michael W. Jakowec; dopamine receptor diversity - anatomy function and relevance to Parkinson's Disease Deborah C. Mash. Aetiology: genetics Zbigniew K. Wszolek and Matthew Farrer; environmental risk factors for Parkinson's disease Jay M. Gorell and Benjamin A. Rybicki. Medications: amantadine and anticholinergics Joseph S. Chung Allan D. Wu and Mark D. Lew; levodopa Anthony J. Santiago and Stewart A. Factor; dopamine agonists Mark A. Stacy; monoamine oxidase inhibitors in Parkinson's disease Daryl Victor and Cheryl Waters; catechol-o methyltransferase in Parkinson's disease Ronald F. Pfeiffer; investigational pharmacological treatments for Parkinson's disease William Ondo. Surgical therapy: lesion surgeries Michael Samuel and Anthony E. Lang; deep brain stimulation in Parkinson's disease Rajesh Pahwa and Kelly E. Lyons; neural transplantation in Parkinson's disease Elmyra V. Encarcion and Robert A. Hauser. Other forms of treatment: Parkinson's disease symptom management - an interdisciplinary approach Ruth A. Hagestuen Rosemary L. Wichmann and Marjorie L. Johnson.
Background: early iconography of Parkinson's disease Christopher G. Goetz. Clinical aspects: epidemiology of Parkinsonism Ali H. Rajput Alex Rajput and Michele Rajput; differential diagnosis of Parkinsonism Kapil D. Sethi; pathophysiology and clinical assessment of Parkinsonian symptoms and signs Joseph Jankovic; nonmotor symptoms of Parkinson's disease Richard B. Dewey Jr; neuropsychological aspects of Parkinson's disease and Parkinsonian syndromes Alexander I. Troster and Steven Paul Woods; treatment of mental changes Jorge Juncos; neuroimaging in Parkinson's disease Kenneth Marek Danna Jennings and John Seibyl. Pathology and neurochemistry: neuropathology of Parkinsonism Dennis W. Dickson; neurochemistry Jayaraman Rao; neurophysiology/circuitry Erwin Montgomery; animal models of Parkinson's disease and related disorders Giselle M. Petzinger and Michael W. Jakowec; dopamine receptor diversity - anatomy function and relevance to Parkinson's Disease Deborah C. Mash. Aetiology: genetics Zbigniew K. Wszolek and Matthew Farrer; environmental risk factors for Parkinson's disease Jay M. Gorell and Benjamin A. Rybicki. Medications: amantadine and anticholinergics Joseph S. Chung Allan D. Wu and Mark D. Lew; levodopa Anthony J. Santiago and Stewart A. Factor; dopamine agonists Mark A. Stacy; monoamine oxidase inhibitors in Parkinson's disease Daryl Victor and Cheryl Waters; catechol-o methyltransferase in Parkinson's disease Ronald F. Pfeiffer; investigational pharmacological treatments for Parkinson's disease William Ondo. Surgical therapy: lesion surgeries Michael Samuel and Anthony E. Lang; deep brain stimulation in Parkinson's disease Rajesh Pahwa and Kelly E. Lyons; neural transplantation in Parkinson's disease Elmyra V. Encarcion and Robert A. Hauser. Other forms of treatment: Parkinson's disease symptom management - an interdisciplinary approach Ruth A. Hagestuen Rosemary L. Wichmann and Marjorie L. Johnson.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
